GHO Capital snaps up Genesis Research in latest pharma services bet

The health outcomes research (HEOR) and Real-World Evidence research organization joins GHO's growing umbrella of pharma services companies taking a transatlantic strategy.

BySarah Pringle

15 November 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Featured Top Stories

GHO Capital snaps up Genesis Research in latest pharma services bet

Related articles